Pharmacological fMRI: A New Tool for Drug Development in Humans
- 1 October 2001
- journal article
- research article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 14 (5), 368-375
- https://doi.org/10.1106/qacm-fbx4-90uk-frw6
Abstract
Until now, our understanding of human brain pharmacology has depended on indirect assessments or animal models. The advent of pharmacological functional magnetic resonance imaging (phMRI) has enabled researchers to focus directly on human pharmacology and brain function. Functional MRI, with its increased spatial and temporal resolution, has a further advantage over other neuroimaging methods in that being totally noninvasive, it allows serial, longitudinal studies to be performed on the same subject. This opens the door to a new era of phMRI, as the effects of drugs can be readily monitored in one subject (control or patient) over time. In addition, sophisticated paradigms can be developed that can isolate specific brain regions of activation. These regions can then be subsequently targeted and challenged with appropriate drugs. This allows for a “battery” of paradigms aimed at determining a drug’s mechanism and site of action, which would be valuable for drug development and discovery.Keywords
This publication has 14 references indexed in Scilit:
- Prospects for Human Pharmacological Functional Magnetic Resonance Imaging (phMRI)The Journal of Clinical Pharmacology, 2001
- Low-dose remifentanil increases regional cerebral blood flow and regional cerebral blood volume, but decreases regional mean transit time and regional cerebrovascular resistance in volunteersBritish Journal of Anaesthesia, 2000
- Cerebral Functional Magnetic Resonance Imaging Activation Modulated by a Single Dose of the Monoamine Neurotransmission Enhancers Fluoxetine and Fenozolone during Hand Sensorimotor TasksJournal of Cerebral Blood Flow & Metabolism, 1999
- Determination of drug-induced changes in functional MRI signal using a pharmacokinetic modelHuman Brain Mapping, 1999
- Effects of sedation, stimulation, and placebo on cerebral blood oxygenation: a magnetic resonance neuroimaging study of psychotropic drug actionNMR in Biomedicine, 1999
- Nicotine-Induced Limbic Cortical Activation in the Human Brain: A Functional MRI StudyAmerican Journal of Psychiatry, 1998
- Cocaine Decreases Cortical Cerebral Blood Flow but Does Not Obscure Regional Activation in Functional Magnetic Resonance Imaging in Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1998
- Event-related functional MRI: Past, present, and futureProceedings of the National Academy of Sciences of the United States of America, 1998
- Acute Effects of Cocaine on Human Brain Activity and EmotionNeuron, 1997
- Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.Proceedings of the National Academy of Sciences of the United States of America, 1992